Technical Analysis for DAWN - Day One Biopharmaceuticals, Inc.

Grade Last Price % Change Price Change
D 22.42 1.91% 0.42
DAWN closed down 0.05 percent on Wednesday, September 22, 2021, on 76 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Down Down
Historical DAWN trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 1.91%
NR7 Range Contraction 1.91%
Lower Bollinger Band Walk Weakness 1.91%
Wide Bands Range Expansion 1.91%
Oversold Stochastic Weakness 1.91%
New Downtrend Bearish 1.86%
Lower Bollinger Band Walk Weakness 1.86%
Inside Day Range Contraction 1.86%
Wide Bands Range Expansion 1.86%
Lower Bollinger Band Touch Weakness 1.86%
Older End-of-Day Signals for DAWN ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakout 9 minutes ago
Rose Above Previous Day's High 9 minutes ago
Up 2% 9 minutes ago
Up 1% about 1 hour ago
60 Minute Opening Range Breakout about 20 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/progressive low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California.

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancers Enzymes Signal Transduction Protein Kinase Inhibitors Protein Kinase Kinase Fibrosarcoma Ym Biosciences

Is DAWN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 28.7
52 Week Low 17.1941
Average Volume 117,412
200-Day Moving Average 0.00
50-Day Moving Average 24.35
20-Day Moving Average 25.42
10-Day Moving Average 23.71
Average True Range 1.80
ADX 26.62
+DI 10.83
-DI 30.23
Chandelier Exit (Long, 3 ATRs) 23.29
Chandelier Exit (Short, 3 ATRs) 25.26
Upper Bollinger Bands 29.71
Lower Bollinger Band 21.14
Percent B (%b) 0.1
BandWidth 33.71
MACD Line -0.74
MACD Signal Line -0.13
MACD Histogram -0.6112
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 22.89
Resistance 3 (R3) 22.93 22.68 22.74
Resistance 2 (R2) 22.68 22.45 22.66 22.69
Resistance 1 (R1) 22.34 22.32 22.22 22.30 22.64
Pivot Point 22.09 22.09 22.03 22.07 22.09
Support 1 (S1) 21.75 21.86 21.63 21.71 21.36
Support 2 (S2) 21.50 21.73 21.48 21.31
Support 3 (S3) 21.16 21.50 21.26
Support 4 (S4) 21.12